
Endocrinology/Hormones
Endocrinology/hormone inhibitors are compounds that block the action of hormones or interfere with hormone signaling pathways. These inhibitors are essential for studying the regulation of endocrine systems and for developing treatments for hormone-related diseases, such as diabetes, thyroid disorders, and hormone-dependent cancers. By modulating hormone activity, these inhibitors can help elucidate the complex interactions within the endocrine system. At CymitQuimica, we offer a wide range of high-quality endocrinology/hormone inhibitors to support your research in endocrinology, pharmacology, and medical sciences.
Subcategories of "Endocrinology/Hormones"
- Androgen Receptor(207 products)
- Annexin A(11 products)
- Aromatase(20 products)
- Estrogen/progestogen Receptor(49 products)
- GPR(1 products)
- Glucocorticoid Receptor(153 products)
- LHRH(1 products)
- Opioid Receptor(296 products)
- Prostaglandin Receptor(119 products)
- RAAS(86 products)
- Reductase(52 products)
- Somatostatin(46 products)
- Thyroid hormone receptor(THR)(26 products)
- Vasopressin Receptor(44 products)
Show 6 more subcategories
Found 3178 products of "Endocrinology/Hormones"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Angiotensin amide
CAS:<p>Angiotensin amide, an octapeptide amide, can be used to increase blood pressure by vasoconstriction.</p>Formula:C49H70N14O11Purity:98%Color and Shape:SolidMolecular weight:1031.17PROTAC ER Degrader-3
CAS:<p>PROTAC ER Degrader-3 from patent WO2017201449A1 is a PAC synthesis intermediate for ADC/PROTAC antibody conjugates, boosting ERα degradation.</p>Formula:C71H77N7O12Purity:98%Color and Shape:SolidMolecular weight:1220.434UFP-101
CAS:<p>Strong, selective NOP receptor antagonist with pKi=10.24; >3000x selectivity over δ, μ, κ receptors; blocks nociceptin effects.</p>Formula:C82H138N32O21Purity:98%Color and Shape:SolidMolecular weight:1908.19Biphalin TFA
CAS:<p>Biphalin TFA is an opioid peptide analog that penetrates the blood-brain barrier (BBB) and encompasses two active enkephalin pharmacophores.</p>Formula:C46H56N10O10·xC2HF3O2Purity:98%Color and Shape:SolidMolecular weight:909.00 (free base)Antitumor agent-195
<p>Antitumor agent-195 (compound 16c) is a dual-targeting agent that simultaneously targets STAT3 and NQO1. At a concentration of 1 μM, it significantly inhibits the phosphorylation of STAT3 at the Tyr705 site and effectively induces apoptosis in MDA-MB-231 and MDA-MB-468 breast cancer cells. As a substrate of NQO1, Antitumor agent-195 markedly increases ROS production, causing severe DNA damage in a dose-dependent manner. It also demonstrates strong antitumor properties in MDA-MB-231 xenograft models.</p>Formula:C22H22N2O4Color and Shape:SolidMolecular weight:378.42TRV055 acetate
<p>TRV055 acetate is a ligand of angiotensin II type 1 receptor and stimulates cellular Gq-mediated signaling.</p>Formula:C44H61N9O11Purity:99.84%Color and Shape:SolidMolecular weight:892.01ARD-2585
CAS:<p>ARD-2585 is an orally active and selective androgen receptor PROTAC degrader with anticancer activity for the study of prostate cancer.</p>Formula:C41H43ClN8O5Color and Shape:SolidMolecular weight:763.28BigLEN(mouse)
CAS:<p>GPR171 agonist from ProSAAS controls mouse appetite, reduces glutamate in paraventricular neurons via G protein.</p>Formula:C78H130N24O22Purity:98%Color and Shape:SolidMolecular weight:1756.03(rel)-PROTAC ERRα Degrader-1
<p>(rel)-PROTAC ERRα Degrader-1 is a relative configuration of PROTAC ERRα Degrader-1, which is an estrogen-related receptor alpha (ERRa) degrader.</p>Formula:C54H49Cl2F6N7O8Purity:98%Color and Shape:SolidMolecular weight:1108.91PROTAC ER Degrader-4
CAS:<p>PROTAC ER Degrader-4 is a PROATC degrader of estrogen receptor (ER)(IC50 of 0.8 nM).</p>Formula:C53H67F3N6O8SPurity:98%Color and Shape:SolidMolecular weight:1005.2GNE-274
CAS:<p>GNE-274, akin to GDC-0927 but non-degrading, is a partial ER agonist in breast cancer, enhancing chromatin at ER sites, inhibiting ER-LBD.</p>Formula:C29H31NO4Color and Shape:SolidMolecular weight:457.573-epi-25-hydroxy Vitamin D3
CAS:<p>3-epi-25-hydroxy Vitamin D3 lowers serum PTH in male weanling rats at 0.5 and 1 IU/g doses; doesn't affect females.</p>Formula:C27H44O2Color and Shape:SolidMolecular weight:400.64U-54494A hydrochloride
CAS:<p>U-54494A hydrochloride is a benzamide derivative related to kappa opioid receptor agonists. U-54494A hydrochloride has anticonvulsant activity.</p>Formula:C18H25Cl3N2OColor and Shape:SolidMolecular weight:391.76Antihypertensive agent 3
<p>Antihypertensive agent 3 (compound 4a), an angiotensin II receptor 1 antagonist, demonstrates antihypertensive activity in spontaneously hypertensive rats (SHRs</p>Formula:C16H13NO4SColor and Shape:SolidMolecular weight:315.34Methylprednisolone Acetate
<p>Methylprednisolone Acetate(Depo-Medrate) has the ability to inhibit oxygen free radicals and can be used to treat acute spinal cord injuries.</p>Formula:C24H32O6Purity:99.74%Color and Shape:Off-White SolidMolecular weight:416.51Axelopran
CAS:<p>Axelopran (TD-1211) treats opioid constipation; it's a potent, selective peripheral opioid blocker.</p>Formula:C26H39N3O4Color and Shape:SolidMolecular weight:457.61SL910102
CAS:<p>SL910102 is a nonpeptide angiotensin antagonist of the AT1 receptor.</p>Formula:C30H30N6OPurity:98%Color and Shape:SolidMolecular weight:490.60PTP1B/AKR1B1-IN-1
<p>PTP1B/AKR1B1-IN-1 is a dual inhibitor targeting protein tyrosine phosphatase 1B (PTP1B) and aldose reductase (AKR1B1), exhibiting inhibitory potency with IC50s</p>Formula:C22H21NO4S2Purity:98%Color and Shape:SolidMolecular weight:427.54Myrciacetin
CAS:<p>Myrciacetin from Rhododendron inhibits rat aldose reductase with IC50 of 13 μM.</p>Formula:C17H16O6Color and Shape:SolidMolecular weight:316.309HINT1-IN-1
<p>HINT1-IN-1 (compound 8) is an inhibitor of histidine triad nucleotide-binding protein 1 (HINT1) with a Ki of 1.14 μM. It influences the cross-regulation between μ-opioid receptors (MOR) and NMDA receptors (NMDAR).</p>Formula:C23H24N8O5Color and Shape:SolidMolecular weight:492.49

